M&A - Passley Shaun

Form Type: SCHEDULE 13D

Filing Date: 2025-03-31

Corporate Action: Acquisition

Type: New

Accession Number: 000137647425000302

Filing Summary: The Schedule 13D is filed on behalf of Epazz, Inc., Ameritek Ventures, Inc., and Dr. Shaun Passley, following the minority shareholder approval of the acquisition of certain assets from Epazz and Ameritek by ZenaTech, Inc. at an Annual and Special Meeting held on March 17, 2025. Dr. Passley, as the sole director and officer of both Epazz and Ameritek, controls 95% of the voting rights in these companies. The shares acquired in the Issuer include common shares, preferred shares, and super-voting shares, which were issued in exchange for the assets acquired from Epazz and Ameritek. This transaction consolidates his control over a substantial number of shares and voting power, with a total of 136,551,124 votes available assuming full conversion of preferred shares. No additional plans or proposals were noted from the Reporting Persons that relate to future corporate actions. The Issuer's principal executive office is located in Vancouver, British Columbia, Canada, at Suite 600, 777 Hornby Street.

Document Link: View Document